SG3 Management, LLC - SIO GENE THERAPIES INC ownership

Back to all holdings Add to watchlist

SIO GENE THERAPIES INC's ticker is SIOX and the CUSIP is 829399104. A total of 57 filers reported holding SIO GENE THERAPIES INC in Q1 2021. The put-call ratio across all filers is 1.52 and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
SG3 Management, LLC ownership history of SIO GENE THERAPIES INC
ValueSharesWeighting
Q1 2022$0
-100.0%
100
-80.0%
0.00%–
Q4 2021$1,000
-95.5%
500
-95.1%
0.00%
-100.0%
Q3 2021$22,000
-89.5%
10,230
-87.2%
0.00%
-75.0%
Q1 2021$209,000
-26.1%
80,000
-21.2%
0.00%
-20.0%
Q4 2020$283,000–101,500–0.01%–
 Download
Other shareholders
SIO GENE THERAPIES INC shareholders Q1 2021
NameSharesValueWeighting ↓
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of SIO GENE THERAPIES INC shareholders